GHC News Flash: Global Health Roundup – 9/25/2017

Global Health Security is Essential to Ensuring U.S. National Security
The U.S. Centers for Disease Control and Prevention (CDC) advancements in global health security are our country’s best defense against health threats, whether naturally occurring or man-made. In a forthcoming special supplement in CDC’s Emerging Infectious Diseases (EID) journal, the first ever supplement for this peer-reviewed publication, CDC describes progress made in preventing, detecting, and responding to global health threats around the world through strengthening global health security. Today, EID releases the first article in the supplement, U.S. Centers for Disease Control and Prevention and its Partners’ Contributions to Advance Global Health Security, which highlights select accomplishments of CDC and its partners to protect Americans and the global community by supporting containment of health threats at their source. Read the press release.

Brookings Institution Releases New Report on Private Sector Investments in Global Health R&D
The new report from Brookings InstitutionPrivate Sector Investment in Global Health R&D: Spending Levels, Barriers, and Opportunities, includes a first-of-its-kind calculation of how much private industry invests in global health care R&D annually. Recent decades, of course, have seen considerable progress in fighting illnesses around the world. Investments in R&D by the public, private, and non-profit sectors have been crucial to the health gains made to date. Though public sector investment will always be important, maximizing the impact of global health R&D will require a sustained effort on the part of the private sector as well. For that reason, the Brookings Private Sector Global Health R&D Project is dedicated to finding ways to strengthen private investment in this area. In their new report—the second published by the Project—authors Darrell West, John Villasenor, and Jake Schneider examine current private sector spending by pharmaceutical firms, venture capital funds, and impact investors in global health R&D. They analyze three types of R&D spending and, using data from a number of sources, calculate how much the private sector currently invests in each. Read the report.


The U.S. President’s Malaria Initiative is Expanding
On September 21, the U.S. Agency for International Development(USAID) Administrator Mark Green announced the expansion of the U.S.President’s Malaria Initiative (PMI). PMI will launch new country programs in Cameroon, Côte d’Ivoire, Niger, and Sierra Leone, and expand its existing program in Burkina Faso. With the addition of five new focus countries in West and Central Africa, PMI will have programs in 24 countries in sub-Saharan Africa, where malaria remains a significant public health problem.  This is in addition to PMI’s two bilateral programs and targeted support in the Greater Mekong Sub-region in Asia, aimed at combating antimalarial drug resistance. PMI’s country expansion will benefit almost 90 million additional people at risk of malaria. The U.S. government will now contribute to ensuring the availability of effective malaria prevention and control interventions to approximately 332 million people at risk across the west-to-central African corridor from Senegal to Cameroon. Read the press release.


NEWS BITES:

1) On September 11, GHC member Friends of the Global Fight Against AIDS, Tuberculosis, and Malaria issued a press release commending the Senate Committee on Appropriations’s approval of a Fiscal year (FY) 2018 Appropriations Bill, which supports steady funding for The Global Fund, major U.S. bilateral global health programs, and U.S. investments against Tuberculosis (TB).
2) On September 13, the Bill & Melinda Gates Foundation released the Goalkeepers Report, which tracks 18 indicators from the Sustainable Development Goals (SDGs), and utilizes first person accounts from leaders driving progress against the SDGs, highlighting innovations and best practices.
3) GHC member PATH published a new advocacy guideStronger Health Advocates Greater Health Impacts, that can help policymakers and advocates create supportive policies to strengthen markets that make health products accessible to marginalized communities.
4) In early September, DefeatDD released study which provides key insights from Malawi that can help advocates draw attention to the economic burden associated with the treatment costs of diarrhea.
5) The UHC Coalition is offering a limited number of grants to support advocacy and impact around Universal Health Coverage (UHC) Day (December 12) and will accept applications until October 15.